Rep. Sensenbrenner spotlights controversial avian flu studies.
The FDA cautions patients to undergo only approved stem cell treatments.
Regulatory conference highlights need for defined governance of laboratory developed diagnostic testing.
Governmental and nongovernmental action taken to discourage illegal pharmaceutical sales over the Internet.
Advocacy group petitions agency to let generic drug manufacturers update labels.
Hearing discusses how to address potential global crisis.
Committee members urge FDA to expedite releasing industry guidance.
The bill would prohibit government subsidies for healthcare plans that cover abortions.
The FDA proposes to withdraw approval for a breast cancer treatment, with hearing scheduled for June.
Lawsuits over stem cell research could alter current scientific approaches.